Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
Press release: ir.lisata.com/news-releases/…
ir.lisata.com Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for... Lisata regains full development rights to certepetide in the Greater China Region BASKING RIDGE, N.J., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the... Press release: ir.lisata.com/news-releases/…